Company Filing History:
Years Active: 2021
Title: Yosuke Harada: Innovator in Monoclonal Antibody Research
Introduction
Yosuke Harada is a prominent inventor based in Kawasaki, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 2 patents, his work focuses on innovative solutions for diagnosing and treating diseases.
Latest Patents
Harada's latest patents include groundbreaking inventions related to monoclonal antibodies. The first patent is for a monoclonal antibody against FZD10, which provides methods for diagnosing FZD10-related diseases. This invention also includes methods for detecting the FZD10 protein and determining drug efficacy after treatment with FZD10 inhibitors. Additionally, it offers diagnostic reagents containing such an antibody. The second patent pertains to a monoclonal antibody against MELK, which similarly provides methods for diagnosing MELK-associated diseases. This patent includes methods for detecting the MELK protein and determining drug efficacy following treatment with a MELK inhibitor, along with diagnostic reagents containing the antibodies.
Career Highlights
Yosuke Harada is currently associated with Oncotherapy Science, Incorporated, where he continues to advance his research in monoclonal antibodies. His work is pivotal in the development of therapeutic solutions for various diseases.
Collaborations
Harada collaborates with notable colleagues in the field, including Yusuke Nakamura and Tatsuki Yokoseki. Their combined expertise contributes to the innovative research being conducted at Oncotherapy Science.
Conclusion
Yosuke Harada's contributions to monoclonal antibody research are significant and impactful. His patents reflect a commitment to advancing medical science and improving diagnostic methods. The work he is doing at Oncotherapy Science, Incorporated positions him as a key figure in the biotechnology industry.